Approval · Notice of Compliance 10246 · 2009
ZOLINZA: Notice of Compliance 10246
Issued June 11, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10246
- Date
- June 11, 2009
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Histone deacetylase inhibitor / antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOLINZA | 02327619 | Marketed |
Medicinal ingredients
- VORINOSTAT 100 MG per CAP